Skip to main content

Biometry

Contributes to the rigor and reproducibility of cancer research through statistical consultation and mathematical modeling. Supports research in biostatistical methods and data analytics, machine learning, and artificial intelligence for cancer risk prediction and reduction.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Resources

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Berger, Vance, Ph.D. vance.berger@nih.gov 240-276-7142	5E628	Statistician \| Biometry
	Bowles, Heather, Ph.D. heather.bowles@nih.gov 240-276-6794	5E640	Program Officer \| Biometry Cancer Prevention Fellowship Program
	Dodd, Kevin, Ph.D. kevin_dodd@nih.gov 240-276-7021	5E126	Deputy Chief \| Biometry
	Hu, Ping, Sc.D. ping.hu@nih.gov 240-276-7015	5E118	Statistician \| Biometry
	Morris, Lawrence lawrence.morris@nih.gov 240-276-7137	5E112	Program Specialist \| Biometry
	Prorok, Philip C, Ph.D. [C] philip.prorok@nih.gov 240-276-7131		Contractor \| Office of the Director Biometry
	Sirota, Lev, Ph.D. [C] lev.sirota@nih.gov 240-276-5127	5E114	Contractor \| Biometry
	Uzzell, Norwood norwood.uzzell@nih.gov 240-276-7141	5E222	Program Support Assistant \| Biometry
	Xu, Jian-Lun, Ph.D. jian-lun.xu@nih.gov 240-276-7023	5E128	Statistician \| Biometry

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Elmore, Joann G	University Of California Los Angeles United States	Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance	1R01CA288824-01A1	Claire Zhu, Ph.D.
Elswick, Ronald K	Virginia Commonwealth University United States	A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer	5R01CA286799-03	Asad Umar, D.V.M., Ph.D.
Esserman, Laura J	University Of California, San Francisco United States	Extending the Diversity, Reach, and Generalizability of the WISDOM Study	5R01CA237533-05	Claire Zhu, Ph.D.
Esserman, Laura J	University Of California, San Francisco United States	WISDOM: A platform to optimize subtype-specific screening and prevention	5P01CA281826-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Fabian, Carol J.	University Of Kansas Medical Center United States	Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer	5R01CA249437-05	Edward Sauter, M.D., Ph.D.
Fahrmann, Johannes F	University Of Tx Md Anderson Can Ctr United States	Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer	5U01CA282216-03	Claire Zhu, Ph.D.
Faller, Bryan	Decatur Memorial Hospital United States	Heartland Cancer Research NCORP	3UG1CA189830-11S1	Vanessa A. White, M.P.H.
Farrar, Christian T	Massachusetts General Hospital United States	Novel metabolomic contrast probes for human lung cancer characterization	4R01CA273010-04	Guillermo Marquez, Ph.D.
Feng, Ziding	Fred Hutchinson Cancer Center United States	Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)	5U24CA230144-09	Guillermo Marquez, Ph.D.
Fiol, Guilherme Del	University Of Utah United States	GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management	5U24CA274582-03	Christos Patriotis, Ph.D., M.Sc.
Fitzgibbon, Marian L.	University Of Illinois At Chicago United States	Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk	5R01CA250390-05	Young Kim, Ph.D.
Flory, James H	Sloan-Kettering Inst Can Research United States	Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life	5R21CA277464-02	Gabriela Riscuta, M.D., CNS
Flowers, Lisa C.	Emory University United States	Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)	5UG1CA284884-03	Maria Silvina Frech, Ph.D., M.S.
Flowers, Lisa C.	Emory University United States	Screening Strategies Among High-Risk Populations for Anal Cancer	5R01CA285198-03	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flynn, Kathryn E	Medical College Of Wisconsin United States	Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)	5R01CA285925-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.